Additionally, NEK6 and NEK9 both have negative correlations for patient survival outcomes in bladder carcinoma and positive correlations for patient survival outcomes in uterine corpus endometrial carcinoma. This evidence concerns the gene NEK6 and uterine corpus endometrial carcinoma.